# Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured Persons

> **NCT01222468** · PHASE2 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 12 (actual)

## Conditions studied

- Muscle Spasticity as a Result of Spinal Cord Injury

## Interventions

- **DRUG:** nabilone 0.5 mg
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01222468
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-02-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222468, "Effect of Cannabinoids on Spasticity and Neuropathic Pain in Spinal Cord Injured Persons". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01222468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*